zipeprol has been researched along with Addiction, Opioid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acteo, MD; Bowman, E; Butelman, E; Englis, JA; Harrish, L; Jacobson, AE; Mattson, MV; Medzihradsky, F; Patrick, G; Rowlett, JK; Smith, CB; Winger, G; Woods, JH; Woolverton, WL | 1 |
| Diodato, S; Janiri, L; Mannelli, P; Persico, AM; Tempesta, E | 1 |
2 other study(ies) available for zipeprol and Addiction, Opioid
| Article | Year |
|---|---|
Zipeprol: preclinical assessment of abuse potential.
Topics: Animals; Antitussive Agents; Brain; Discrimination Learning; Drug Synergism; Female; Guinea Pigs; Humans; Macaca mulatta; Male; Mice; Mice, Inbred ICR; Motivation; Opioid-Related Disorders; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Risk; Substance Abuse, Intravenous; Substance Withdrawal Syndrome; Substance-Related Disorders | 1996 |
Zipeprol is a newly abused antitussive with an opioid spectrum and hallucinogenic effects.
Topics: Adolescent; Adult; Antitussive Agents; Female; Hallucinations; Humans; Male; Opioid-Related Disorders; Piperazines; Rome; Substance Withdrawal Syndrome; Substance-Related Disorders | 1991 |